Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mercedes L Dalurzo, Alejandro Avilés-Salas, Fernando Augusto Soares, Yingyong Hou, Yuan Li, Anna Stroganova, Büge Öz, Arif Abdillah, Hui Wan & Yoon-La Choi. (2021) Testing for EGFR Mutations and ALK Rearrangements in Advanced Non-Small-Cell Lung Cancer: Considerations for Countries in Emerging Markets. OncoTargets and Therapy 14, pages 4671-4692.
Read now
Read now
Xuhui Zhang, Jiemei Feng, Xiaoxing Su, Yan Lei, Wendy Wu & Xiangyang Cheng. (2020) Next Generation Sequencing Reveals a Synchronous Trilateral Lung Adenocarcinoma Case with Distinct Driver Alterations of EGFR 19 Deletion or EGFR 20 Insertion or EZR-ROS1 Fusion. OncoTargets and Therapy 13, pages 12667-12671.
Read now
Read now
Articles from other publishers (12)
Dandan Li, Hua Jiang, Faguang Jin, Lei Pan, Yonghong Xie, Liang Zhang & Chunmei Li. (2022) Concurrent classic driver oncogenes mutation with ROS1 rearrangement predicts superior clinical outcome in NSCLC patients. Genes & Genomics 45:1, pages 93-102.
Crossref
Crossref
Shrinidhi Nathany, Ullas Batra, Rashi Sachdeva, Mansi Sharma, BP Amrith & Shriya Vaidya. (2022) ROS1 in non-small-cell lung carcinoma: A narrative review. Cancer Research, Statistics, and Treatment 5:4, pages 692.
Crossref
Crossref
Giorgia Guaitoli, Federica Bertolini, Stefania Bettelli, Samantha Manfredini, Michela Maur, Lucia Trudu, Beatrice Aramini, Valentina Masciale, Giulia Grisendi, Massimo Dominici & Fausto Barbieri. (2021) Deepening the Knowledge of ROS1 Rearrangements in Non-Small Cell Lung Cancer: Diagnosis, Treatment, Resistance and Concomitant Alterations. International Journal of Molecular Sciences 22:23, pages 12867.
Crossref
Crossref
Gangothri SelvarajanPerumal Kalaiyarasi Jayachandran. (2021) Dual driver in non-small cell lung carcinoma – therapeutic dilemma. International Journal of Molecular and Immuno Oncology 7, pages 16-19.
Crossref
Crossref
Élia Cipriano, Helena Magalhães, Catarina Tavares, João Pinto, Luís Cirnes & Fernanda Estevinho. (2021) Concurrent EGFR mutation and ALK rearrangement in stage IV lung adenocarcinoma—a case report and a literature review. Porto Biomedical Journal 6:1, pages e124.
Crossref
Crossref
Yijia Guo, Jun Song, Yanru Wang, Letian Huang, Li Sun, Jianzhu Zhao, Shuling Zhang, Wei Jing, Jietao Ma & Chengbo Han. (2020) Concurrent Genetic Alterations and Other Biomarkers Predict Treatment Efficacy of EGFR-TKIs in EGFR-Mutant Non-Small Cell Lung Cancer: A Review. Frontiers in Oncology 10.
Crossref
Crossref
Xilin Zhang, Yan Jiang, Huanming Yu, Hui Xia & Xiang Wang. (2020) A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patients. World Journal of Surgical Oncology 18:1.
Crossref
Crossref
Jing Zheng, Yanping Zhu, Ke Sun, Qian Shen, Yuehong Wang, He Cao, Analyn Lizaso, Bing Yu, Jing Lin, Songan Chen, Jianya Zhou & Jianying Zhou. (2020) Investigation on the prognostic impact of concurrent genomic alterations in crizotinib-treated EML4-ALK-rearranged advanced non-small cell lung cancer patients. Lung Cancer 146, pages 209-216.
Crossref
Crossref
Panwen Tian, Yujie Liu, Hao Zeng, Yuan Tang, Analyn Lizaso, Junyi Ye, Lin Shao & Yalun Li. (2020) Unique molecular features and clinical outcomes in young patients with non-small cell lung cancer harboring ALK fusion genes. Journal of Cancer Research and Clinical Oncology 146:4, pages 935-944.
Crossref
Crossref
Hong-Joon Shin, Bo Gun Kho, Min-Seok Kim, Ha Young Park, Tae-Ok Kim, Yu-Il Kim, Sung-Chul Lim, Cheol-Kyu Park, Young-Chul Kim, Yoo-Duk Choi & In-Jae Oh. (2019) Co-alteration of EGFR mutation and ALK rearrangement in non-small cell lung cancer. Medicine 98:9, pages e14699.
Crossref
Crossref
Jingrui Jiang, Alexei Protopopov, Ruobai Sun, Stephen Lyle & Meaghan Russell. (2018) Genomic Profiling on an Unselected Solid Tumor Population Reveals a Highly Mutated Wnt/β-Catenin Pathway Associated with Oncogenic EGFR Mutations. Journal of Personalized Medicine 8:2, pages 13.
Crossref
Crossref
Laetitia Lambros, Briac Guibourg & Arnaud Uguen. (2018) ROS1-rearranged Non–Small Cell Lung Cancers With Concomitant Oncogenic Driver Alterations: About Some Rare Therapeutic Dilemmas. Clinical Lung Cancer 19:1, pages e73-e74.
Crossref
Crossref